Skip to content
TrackPodcasts
healthJun 28, 20221:13:57pending

Episode #102: Hybrid Peptides, Peptide Research Updates, and Bioregulators

About this episode

My guest this week is Jean-Francois Tremblay of Can Lab. In this episode, Jean-Francois and I discuss peptides and bioregulator peptides. We talk about the TA1/LL-37 hybrid, TA1, LL-37, TB4, GLP-1 agonists and bioregulator peptides such as epitalon and thymalin. We review dosing protocols as well as talk about a NEW peptide. Learn more about Can Lab at https://canlabsciences.com/ and use code OSP15 for 15% off your purchase. Episode Takeaways [06:15] Review of the TA1/LL-37 hybrid… [07:57] What is LL-37 and what does it do?.. [08:50] What is TA1 and what does it help with?.. [16:43] GLP-1 agonists, a game changer… [21:31] All about thymosin alpha 1 RGDR… [27:27] Thymosin Beta 4 and its fragments… [39:22] For bioregulators what is the appropriate dosing?.. [46:45] Can I mix multiple peptides in one syringe?.. Follow Nat Facebook Facebook Group Instagram Youtube Work with Nat: Book Your 20 MInute Optimization Consult

Get every episode summarized

Each time LONGEVITY with Nathalie Niddam publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Episode #102: Hybrid Peptides, Peptide Research Updates, and Bioregulators

LONGEVITY with Nathalie Niddam

0:00
1:13:57

More episodes

More from LONGEVITY with Nathalie Niddam

View all episodes →